GUJARAT THEMIS BIOSYN LTD

GUJTHEM

Small Cap | Pharmaceuticals
₹362
-13.64 (-3.63%)

Stock price as on 30 Apr 2026 at 15:29 PM

Gujarat themis biosyn ltd share price update

As of the latest trading session, Gujarat Themis Biosyn Ltd share price is currently at ₹362, which is down by ₹-13.64 from its previous closing. Toda...

Gujarat Themis Biosyn Ltd stock performance

Today’s low

₹361.03

Today’s high

₹373.49

₹362

52 week low

₹225.05

52 week high

₹479

₹362
Open
₹370.04
Previous close
₹375.64
Share volume
95,014
Total traded value (Lakh)
₹345.45
Upper circuit
₹450.76
Lower circuit
₹300.52

Gujarat Themis Biosyn Ltd fundamentals

Market cap (Cr)
₹3,961.80
P/E ratio (TTM)
82.86
Book value per share
₹24.26
Beta
1.87
Return on equity
21.69%
Earnings per share (TTM)
₹4.39
Dividend yield
0.18%
Net profit/quarter (Cr)
₹12.46

Gujarat Themis Biosyn Ltd technical summary

₹363.58
-3.21 ▼
1
Bearish
15
Bullish
5 Day360.9
10 Day345.9
12 Day340.5
20 Day324.8
26 Day318.6
50 Day315.4
100 Day330.1
200 Day323.3
5 Day357.8
10 Day340.4
12 Day331.9
20 Day304
26 Day295.1
50 Day300.1
100 Day337.9
200 Day369.2

373.99

PIVOT

First support
₹366.65
First resistance
₹382.98
Second support
₹357.66
Second resistance
₹390.32
Third support
₹350.32
Third resistance
₹399.31
RSI
67.75
ADX
27.54
MACD
21.88
Williams % R
-17.95
Commodity Channel Index (CCI)
104.67
Date
30 Apr 2026
Same day
40,994
Week
1,97,945
Month
89,723
1 year
1.88
3 years
-5.67
Over 1 month
60.23%
Over 1 year
31.7%
Over 3 months
12.52%
Over 3 years
0%
Over 6 months
-22.17%
Over 6 years
0%

Investment Returns

Over 1 Month60.23%
Over 3 Months12.52%
Over 6 Months22.17%
Over 1 Year31.7%

Gujarat Themis Biosyn Ltd Shareholding pattern


Public
26.16%
Promoter holdings
70.86%
FII
1.79%
DII
1.17%
Promoter shares
5.44%
Promoter sharesShareCategory

Pharmaceutical Business Group [india] Ltd

5,12,40,000 (47.02%)

Shareholding of Promoter and Promoter Group

Themis Medicare Limited

2,52,72,037 (23.19%)

Shareholding of Promoter and Promoter Group

Quant Mutual Fund - Quant Manufacturing Fund

12,54,000 (1.15%)

Public Shareholding

Vividhmargi Trust (trustees - Dinesh Shantilal Patel, Jayshree Dinesh Patel, Sachin Dinesh Patel And

6,60,302 (0.61%)

Shareholding of Promoter and Promoter Group

Nysha Rupen Choksi

22,852 (0.02%)

Shareholding of Promoter and Promoter Group

Promoter sharesShareCategory
Pharmaceutical Business Group [india] Ltd5,12,40,000 (47.02%)Shareholding of Promoter and Promoter Group
Themis Medicare Limited2,52,72,037 (23.19%)Shareholding of Promoter and Promoter Group
Quant Mutual Fund - Quant Manufacturing Fund12,54,000 (1.15%)Public Shareholding
Vividhmargi Trust (trustees - Dinesh Shantilal Patel, Jayshree Dinesh Patel, Sachin Dinesh Patel And6,60,302 (0.61%)Shareholding of Promoter and Promoter Group
Nysha Rupen Choksi22,852 (0.02%)Shareholding of Promoter and Promoter Group
Anay Rupen Choksi22,852 (0.02%)Shareholding of Promoter and Promoter Group
Dinesh Shantilal Patel10 (0%)Shareholding of Promoter and Promoter Group
Reena S Patel10 (0%)Shareholding of Promoter and Promoter Group
Sachin Dinesh Patel10 (0%)Shareholding of Promoter and Promoter Group
Jayshree D Patel10 (0%)Shareholding of Promoter and Promoter Group

About GUJARAT THEMIS BIOSYN LTD

Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited (GTBL) was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is actively managed b

Parent Organisation

Themis

NSE Symbol

GUJTHEM

Founded

1981

GUJARAT THEMIS BIOSYN LTD CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
04 Sept 20250.67Final05 Sept 2025Equity shares
15 Jul 20240.25Final16 Jul 2024Equity shares
22 Feb 20240.75Interim22 Feb 2024Equity shares
01 Sept 20231Final02 Sept 2023Equity shares
01 Dec 20224.4Interim02 Dec 2022Equity shares
29 Aug 20224Final31 Aug 2022Equity shares
24 Nov 20215Special25 Nov 2021Equity shares
24 Nov 20212Interim25 Nov 2021Equity shares
10 Sept 20201.65Final14 Sept 2020Equity shares

View more stocks

What’s trending

All stocks

BALCO

SOLVE PLASTIC PRODUCTS L

31.4
+8.55 (+37.42%)
ADISOFT

ADISOFT TECHNOLOGIES LTD

215.25
+43.25 (+25.15%)
CEMPRO

CEMINDIA PROJECTS LIMITED

815.25
+135.85 (+20%)
CEMPRO

CEMINDIA PROJECTS LIMITED

814.55
+135.75 (+20%)
View all

Top gainers

BAJAJ-AUTO

BAJAJ AUTO LIMITED

9994
+450.50 (+4.72%)
SUNPHARMA

SUN PHARMACEUTICAL IND L

1808.3
+29.60 (+1.66%)
INFY

INFOSYS LIMITED

1181.8
+14.30 (+1.22%)
TECHM

TECH MAHINDRA LIMITED

1473.5
+13.70 (+0.94%)
View all

Top losers

TMPV

TATA MOTORS PASS VEH LTD

341.55
-11.15 (-3.16%)
ETERNAL

ETERNAL LIMITED

247.03
-7.00 (-2.76%)
HINDALCO

HINDALCO INDUSTRIES LTD

1038
-29.20 (-2.74%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2250.9
-63.50 (-2.74%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)